世界のパンデミックインフルエンザワクチン市場予測 2021年-2026年

◆英語タイトル:Global Pandemic Influenza Vaccine Market Growth 2021-2026
◆商品コード:LPI21JL16686
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月
◆ページ数:92
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
LP Information社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

LPインフォメーション社の「パンデミックインフルエンザワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチンなど、用途別には、子供(6ヶ月から3歳)、大人&3歳以上子供などにセグメント区分してまとめました。パンデミックインフルエンザワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・パンデミックインフルエンザワクチンの世界市場概要(サマリー)
・パンデミックインフルエンザワクチンの企業別販売量・売上
・パンデミックインフルエンザワクチンの企業別市場シェア
・パンデミックインフルエンザワクチンの世界市場規模 2016年-2021年:種類別(全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン)
・パンデミックインフルエンザワクチンの世界市場規模 2016年-2021年:用途別(子供(6ヶ月から3歳)、大人&3歳以上子供)
・パンデミックインフルエンザワクチンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・パンデミックインフルエンザワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・パンデミックインフルエンザワクチンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・パンデミックインフルエンザワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・パンデミックインフルエンザワクチン市場の成長要因・課題・動向
・パンデミックインフルエンザワクチンの世界市場予測 2021年-2026年
・パンデミックインフルエンザワクチンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・パンデミックインフルエンザワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・パンデミックインフルエンザワクチンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・パンデミックインフルエンザワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・パンデミックインフルエンザワクチンの世界市場予測:種類別(全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン)
・パンデミックインフルエンザワクチンの世界市場予測:用途別(子供(6ヶ月から3歳)、大人&3歳以上子供)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Pandemic Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Pandemic Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pandemic Influenza Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pandemic Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
For Children (6 months to 3 years)
For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pandemic Influenza Vaccine Consumption 2016-2026
2.1.2 Pandemic Influenza Vaccine Consumption CAGR by Region
2.2 Pandemic Influenza Vaccine Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.3 Pandemic Influenza Vaccine Sales by Type
2.3.1 Global Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pandemic Influenza Vaccine Sale Price by Type (2016-2021)
2.4 Pandemic Influenza Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Pandemic Influenza Vaccine Sales by Application
2.5.1 Global Pandemic Influenza Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pandemic Influenza Vaccine Sale Price by Application (2016-2021)

3 Global Pandemic Influenza Vaccine by Company
3.1 Global Pandemic Influenza Vaccine Sales Market Share by Company
3.1.1 Global Pandemic Influenza Vaccine Sales by Company (2019-2021)
3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Pandemic Influenza Vaccine Revenue Market Share by Company
3.2.1 Global Pandemic Influenza Vaccine Revenue by Company (2019-2021)
3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Pandemic Influenza Vaccine Sale Price by Company
3.4 Global Manufacturers Pandemic Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pandemic Influenza Vaccine Product Location Distribution
3.4.2 Players Pandemic Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pandemic Influenza Vaccine by Region
4.1 Global Pandemic Influenza Vaccine by Region
4.1.1 Global Pandemic Influenza Vaccine Sales by Region
4.1.2 Global Pandemic Influenza Vaccine Revenue by Region
4.2 Americas Pandemic Influenza Vaccine Sales Growth
4.3 APAC Pandemic Influenza Vaccine Sales Growth
4.4 Europe Pandemic Influenza Vaccine Sales Growth
4.5 Middle East & Africa Pandemic Influenza Vaccine Sales Growth

5 Americas
5.1 Americas Pandemic Influenza Vaccine Sales by Country
5.1.1 Americas Pandemic Influenza Vaccine Sales by Country (2016-2021)
5.1.2 Americas Pandemic Influenza Vaccine Revenue by Country (2016-2021)
5.2 Americas Pandemic Influenza Vaccine Sales by Type
5.3 Americas Pandemic Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Pandemic Influenza Vaccine Sales by Region
6.1.1 APAC Pandemic Influenza Vaccine Sales by Region (2016-2021)
6.1.2 APAC Pandemic Influenza Vaccine Revenue by Region (2016-2021)
6.2 APAC Pandemic Influenza Vaccine Sales by Type
6.3 APAC Pandemic Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Pandemic Influenza Vaccine by Country
7.1.1 Europe Pandemic Influenza Vaccine Sales by Country (2016-2021)
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Country (2016-2021)
7.2 Europe Pandemic Influenza Vaccine Sales by Type
7.3 Europe Pandemic Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Pandemic Influenza Vaccine by Country
8.1.1 Middle East & Africa Pandemic Influenza Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Pandemic Influenza Vaccine Sales by Type
8.3 Middle East & Africa Pandemic Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pandemic Influenza Vaccine Distributors
10.3 Pandemic Influenza Vaccine Customer

11 Global Pandemic Influenza Vaccine Market Forecast
11.1 Global Pandemic Influenza Vaccine Forecast by Region
11.1.1 Global Pandemic Influenza Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pandemic Influenza Vaccine Forecast by Type
11.7 Global Pandemic Influenza Vaccine Forecast by Application

12 Key Players Analysis
12.1 CSL
12.1.1 CSL Company Information
12.1.2 CSL Pandemic Influenza Vaccine Product Offered
12.1.3 CSL Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CSL Main Business Overview
12.1.5 CSL Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Pandemic Influenza Vaccine Product Offered
12.2.3 GSK Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Company Information
12.3.2 Sanofi Pasteur Pandemic Influenza Vaccine Product Offered
12.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi Pasteur Main Business Overview
12.3.5 Sanofi Pasteur Latest Developments
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Pandemic Influenza Vaccine Product Offered
12.4.3 Mylan Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Main Business Overview
12.4.5 Mylan Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Pandemic Influenza Vaccine Product Offered
12.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Pandemic Influenza Vaccine Product Offered
12.6.3 Pfizer Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pfizer Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Information
12.7.2 Johnson & Johnson Pandemic Influenza Vaccine Product Offered
12.7.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Johnson & Johnson Main Business Overview
12.7.5 Johnson & Johnson Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Pandemic Influenza Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Whole Virus Vaccines
Table 3. Major Players of Split Virus Vaccines
Table 4. Major Players of Subunit Vaccines
Table 5. Global Pandemic Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 6. Global Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Pandemic Influenza Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Pandemic Influenza Vaccine Sale Price by Type (2016-2021)
Table 10. Global Pandemic Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 11. Global Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Pandemic Influenza Vaccine Value by Application (2016-2021)
Table 13. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Pandemic Influenza Vaccine Sale Price by Application (2016-2021)
Table 15. Global Pandemic Influenza Vaccine Sales by Company (2019-2021) & (K Doses)
Table 16. Global Pandemic Influenza Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Pandemic Influenza Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Pandemic Influenza Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Pandemic Influenza Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Pandemic Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pandemic Influenza Vaccine Products Offered
Table 22. Pandemic Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pandemic Influenza Vaccine Sales by Region (2016-2021) (K Doses)
Table 26. Global Pandemic Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Pandemic Influenza Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 30. Americas Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Pandemic Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Pandemic Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 34. Americas Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Pandemic Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 36. Americas Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Pandemic Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 38. APAC Pandemic Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Pandemic Influenza Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Pandemic Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Pandemic Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 42. APAC Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Pandemic Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 44. APAC Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 46. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Pandemic Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Pandemic Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 50. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Pandemic Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 52. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 54. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 58. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 60. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Pandemic Influenza Vaccine
Table 62. Key Application and Potential Industries of Pandemic Influenza Vaccine
Table 63. Key Challenges of Pandemic Influenza Vaccine
Table 64. Key Trends of Pandemic Influenza Vaccine
Table 65. Pandemic Influenza Vaccine Distributors List
Table 66. Pandemic Influenza Vaccine Customer List
Table 67. Global Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) & (K Doses)
Table 68. Global Pandemic Influenza Vaccine Consumption Market Forecast by Region
Table 69. Global Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) & (K Doses)
Table 72. Americas Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) & (K Doses)
Table 74. APAC Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) & (K Doses)
Table 76. Europe Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) & (K Doses)
Table 78. Middle East & Africa Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
Table 80. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
Table 84. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 87. CSL Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. CSL Pandemic Influenza Vaccine Product Offered
Table 89. CSL Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 90. CSL Main Business
Table 91. CSL Latest Developments
Table 92. GSK Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Pandemic Influenza Vaccine Product Offered
Table 94. GSK Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Sanofi Pasteur Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Pandemic Influenza Vaccine Product Offered
Table 99. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Mylan Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Mylan Pandemic Influenza Vaccine Product Offered
Table 104. Mylan Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 105. Mylan Main Business
Table 106. Mylan Latest Developments
Table 107. AstraZeneca Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. AstraZeneca Pandemic Influenza Vaccine Product Offered
Table 109. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 110. AstraZeneca Main Business
Table 111. AstraZeneca Latest Developments
Table 112. Pfizer Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Pandemic Influenza Vaccine Product Offered
Table 114. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Johnson & Johnson Basic Information, Pandemic Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Johnson & Johnson Pandemic Influenza Vaccine Product Offered
Table 119. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 120. Johnson & Johnson Main Business
Table 121. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Picture of Pandemic Influenza Vaccine
Figure 2. Pandemic Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pandemic Influenza Vaccine Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Pandemic Influenza Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pandemic Influenza Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Whole Virus Vaccines
Figure 10. Product Picture of Split Virus Vaccines
Figure 11. Product Picture of Subunit Vaccines
Figure 12. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020
Figure 13. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Pandemic Influenza Vaccine Consumed in For Children (6 months to 3 years)
Figure 15. Global Pandemic Influenza Vaccine Market: For Children (6 months to 3 years) (2016-2021) & (K Doses)
Figure 16. Pandemic Influenza Vaccine Consumed in For Adults and Children over 3 years
Figure 17. Global Pandemic Influenza Vaccine Market: For Adults and Children over 3 years (2016-2021) & (K Doses)
Figure 18. Global Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 19. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2020
Figure 20. Pandemic Influenza Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Pandemic Influenza Vaccine Revenue Market Share by Company in 2020
Figure 22. Global Pandemic Influenza Vaccine Sales Market Share by Regions (2016-2021)
Figure 23. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2020
Figure 24. Americas Pandemic Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 25. Americas Pandemic Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 26. APAC Pandemic Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 27. APAC Pandemic Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 28. Europe Pandemic Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 29. Europe Pandemic Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Pandemic Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 31. Middle East & Africa Pandemic Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Americas Pandemic Influenza Vaccine Sales Market Share by Country in 2020
Figure 33. Americas Pandemic Influenza Vaccine Revenue Market Share by Country in 2020
Figure 34. Americas Pandemic Influenza Vaccine Sales Market Share by Type in 2020
Figure 35. Americas Pandemic Influenza Vaccine Sales Market Share by Application in 2020
Figure 36. United States Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Pandemic Influenza Vaccine Sales Market Share by Region in 2020
Figure 41. APAC Pandemic Influenza Vaccine Revenue Market Share by Regions in 2020
Figure 42. APAC Pandemic Influenza Vaccine Sales Market Share by Type in 2020
Figure 43. APAC Pandemic Influenza Vaccine Sales Market Share by Application in 2020
Figure 44. China Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2020
Figure 51. Europe Pandemic Influenza Vaccine Revenue Market Share by Country in 2020
Figure 52. Europe Pandemic Influenza Vaccine Sales Market Share by Type in 2020
Figure 53. Europe Pandemic Influenza Vaccine Sales Market Share by Application in 2020
Figure 54. Germany Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Pandemic Influenza Vaccine Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Application in 2020
Figure 63. Egypt Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Pandemic Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のパンデミックインフルエンザワクチン市場予測 2021年-2026年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆